Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Carboxylic acids and derivatives >  (S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid

(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid

Basic information Safety Supplier Related

(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid Basic information

Product Name:
(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid
Synonyms:
  • (S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid
  • (2S)-4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid
  • 1,2-Piperidinedicarboxylic acid, 4,4-difluoro-, 1-(1,1-dimethylethyl) ester, (2S)-
  • (2S)-1-[(tert-butoxy)carbonyl]-4,4-difluoropiperidine-2-carboxylic acid
  • (S)-l-(TERTBUTOXYCARBONYL)-4, 4-DIFLUOROPIPERIDINE-2-rARRHYVI TC ACTD
  • (S)-1-Boc-4,4-difluoropiperidine-2-carboxylic Acid
  • (2S)-1-[(tert-butoxy)carbonyl]-4,4-difluoropiperidine-2-carboxylic acid - [B89102]
CAS:
1221793-42-5
MF:
C11H17F2NO4
MW:
265.25
Mol File:
1221793-42-5.mol
More
Less

(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid Chemical Properties

Boiling point:
356.4±42.0 °C(Predicted)
Density 
1.27±0.1 g/cm3(Predicted)
pka
3.20±0.40(Predicted)
More
Less

(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid Usage And Synthesis

Synthesis

1352342-07-4

1221793-42-5

General procedure for the synthesis of (S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid from compound (CAS: 1352342-07-4): compound 2 (1.526 g, 5.462 mmol) was dissolved in tetrahydrofuran (11 mL), methanol (11 mL), and 1N aqueous potassium hydroxide (11 mL, 11 mmol). It was stirred at room temperature for 1.5 hours. Subsequently, 1N aqueous potassium hydroxide solution (5.5 mL, 5.5 mmol) was added and stirring was continued for 1 hour. After completion of the reaction, the mixture was concentrated to half the original volume, diluted with water and washed once with ether. The aqueous phase was acidified with 1N hydrochloric acid (20 mL) and extracted twice with ethyl acetate. The organic phases were combined, washed once with saturated brine, dried over anhydrous sodium sulfate and concentrated to give compound 3 (1.429 g, 98% yield). Mass spectrometry analysis showed [M-H]? = 264.2.

References

[1] Patent: WO2011/156610, 2011, A2. Location in patent: Page/Page column 102
[2] Patent: CN106928127, 2017, A. Location in patent: Paragraph 0232; 0243; 0244; 0245; 0246; 0247
[3] Patent: WO2015/5901, 2015, A1. Location in patent: Page/Page column 528; 529

(S)-1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acidSupplier

Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
TaiChem Taizhou Limited
Tel
052386810091
Email
zcwy9518@yeah.net
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Aikon International Limited
Tel
025-66061636 18013972705
Email
qqyang@aikonchem.com
Jinan Carbotang Biotech Co.,Ltd.
Tel
+8615866703830
Email
figo.gao@foxmail.com